NOC vs SYK
Northrop Grumman Corp. and Stryker Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | NOC | SYK |
|---|---|---|
| Revenue | $42.0B | $25.1B |
| Net income | $4.2B | $3.2B |
| Gross margin | — | 64.0% |
| Net margin | 10.0% | 12.9% |
| Return on equity | 26.2% | — |
| Diluted EPS | $29.08 | $8.40 |
| Dividend / share | $8.99 | — |
| Payout ratio | 30.9% | 39.6% |
| Free cash flow | $3.3B | $4.3B |
| Equity | $16.7B | — |
| Net debt / equity | 0.68× | — |
| Current ratio | 1.10× | 1.89× |
| Revenue CAGR 5y | 2.7% | 11.8% |
| Profit CAGR 5y | 5.6% | 15.2% |
NOC bills 1.7× the revenue of SYK, and SYK keeps more of each dollar of revenue as profit (12.9% against 10.0%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | NOC | SYK |
|---|---|---|
| FY2025 | $42.0B | $25.1B |
| FY2024 | $41.0B | $22.6B |
| FY2023 | $39.3B | $20.5B |
| FY2022 | $36.6B | $18.4B |
| FY2021 | $35.7B | $17.1B |
| FY2020 | $36.8B | $14.4B |
| FY2019 | $33.8B | $14.9B |
| FY2018 | $30.1B | $13.6B |
| FY2017 | $26.0B | $12.4B |
| FY2016 | $24.7B | $11.3B |
Net income by year
Bottom line
| Fiscal year | NOC | SYK |
|---|---|---|
| FY2025 | $4.2B | $3.2B |
| FY2024 | $4.2B | $3.0B |
| FY2023 | $2.1B | $3.2B |
| FY2022 | $4.9B | $2.4B |
| FY2021 | $7.0B | $2.0B |
| FY2020 | $3.2B | $1.6B |
| FY2019 | $2.2B | $2.1B |
| FY2018 | $3.2B | $3.6B |
| FY2017 | $2.9B | $1.0B |
| FY2016 | $2.0B | $1.6B |